Clinical Trials Directory

Trials / Completed

CompletedNCT03481517

Wound Infiltration With Local Anesthetic Agent for Laparoscopic Appendectomy in Adult

The Interest of Wound Infiltration With Local Anesthetic Agent for Laparoscopic Appendectomy in Adult: a Double Blind, Prospective, Randomized Control Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
47 (actual)
Sponsor
National Taiwan University Hospital · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

Acute appendicitis is one of the most common acute abdomens that need surgical intervention. Laparoscopic surgery much decreases postoperative pain of wound, however, pain remains an important determinant of recovery after surgery. Intraoperative local anesthetic agent infiltrated locally into surgical wound to relieve postoperative pain is a feasible and safe method suggested in some literature. However, there is no routine use of this method in clinical practice because its benefit is still unknown. Besides, very few evidence could be found in literature review. To date, there is still no double blinded, prospective, randomized control trial addressing in evaluation of its interest. In this study, the investigators aim at investigating the benefit of wound infiltration with local anesthetic agent (bupivacaine) for laparoscopic appendectomy in adult. The study design is a double blind, prospective, randomized control trial with a 1:1 allocation ratio. Fifty adult patients with appendicitis will be included. The control group undergo laparoscopic appendectomy without wound infiltration with local anesthetic agent, the intervention group undergo laparoscopic appendectomy with wound infiltration with local anesthetic agent intraoperatively. The clinical characteristics, outcomes, and patient's satisfaction will be recorded and analyzed. The investigators hope this study can provide a high level evidence in pain management of patient undergo laparoscopic surgery.

Conditions

Interventions

TypeNameDescription
DRUGBupivacaineBupivacaine 5 mL subcutaneous injection to surgical wound during operation.

Timeline

Start date
2018-04-23
Primary completion
2019-07-08
Completion
2019-07-31
First posted
2018-03-29
Last updated
2020-04-27

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT03481517. Inclusion in this directory is not an endorsement.